Jane Street Group, LLC I Bio, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$0.55 - $1.04 $16,170 - $30,576
-29,400 Reduced 26.85%
80,100 $44,000
Q3 2021

Nov 16, 2021
SELL
$1.06 - $1.52 $48,972 - $70,224
-46,200 Reduced 29.67%
109,500 $116,000
Q2 2021

Aug 16, 2021
BUY
$1.22 - $1.65 $96,014 - $129,855
78,700 Added 102.21%
155,700 $235,000
Q1 2021

May 18, 2021
BUY
$1.18 - $2.62 $90,860 - $201,740
77,000 New
77,000 $119,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email